Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics Life Science Investing
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 Life Science Investing
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results Life Science Investing
Biogen to Share New SMA Data at Muscular Dystrophy Association and SMA Europe Conferences Life Science Investing
Compass Therapeutics Reports 2025 Financial Results and Provides Corporate Update Life Science Investing
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat Life Science Investing
GH Research Reports Full Year 2025 Financial Results and Provides Business Update Life Science Investing
Climb Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates Life Science Investing
Shattuck Labs Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Highlights Life Science Investing
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome Life Science Investing
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board for Phase 3 Study in Metastatic Breast Cancer
